1. Home
  2. Live Updates
  3. Taimed biologics

Live Breaking News & Updates on Taimed biologics

Stay informed with the latest breaking news from Taimed biologics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Taimed biologics and stay connected to the pulse of your community

TaiMed and AcedrA partner to commercialise Trogarzo

Taimed Biologics, a publicly held Taiwanese biotechnology company, has signed deal with AcedrA BioPharmaceuticals to promote and commercialise Trogarzo (Ibalizumab-uiyk) in the Mena region.


Taiwan , Riyadh , Ar-riya- , Saudi-arabia , Taiwanese , Jimmy-chang , Taimed-biologics , Trogarzo-ibalizumab-uiyk , Drug-administration , Acedra-biopharmaceuticals , Human-immunodeficiency-virus , Acquired-immune-deficiency-syndrome

A28 Therapeutics Targets Tumors - San Diego Business Journal

A28 Therapeutics Targets Tumors - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

La-jolla , California , United-states , United-kingdom , San-diego , America , Barack-obama , Stanley-lewis , Taimed-biologics , Emmett-till , Rhonda-wallen , Democratic-party

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United-states , Taipei , T-ai-pei , Taiwan , Taimed-biologics , Taimed-biologics-inc , Med-biologics ,

Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study

Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Montreal , Quebec , Canada , United-states , Taimed-biologics , Julie-schneiderman , Theratechnologies-inc , Twitter , Linkedin , Communications-corporate-affairs , Drug-administration , Sodium-chloride-injection

Theratechnologies : Financial Document -September 26, 2023 at 08:35 am EDT

MANAGEMENT'S DISCUSSION AND ANALYSIS


FOR THE THREE-ANDNINE-MONTH PERIODS ENDED AUGUST 31, 2023


The following Management's Discussion and...

Russia , Norway , United-states , Israel , Switzerland , Quebec , Canada , Montreal , America , Taimed-biologics-inc , Drug-administration

Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and ...

Q4 2022 consolidated revenue growth of 14.2% to $21.4 millionFY2022 revenue totaled $80.1 million or growth of ~15%, in line with guidanceFY2023 operating plan to focus on achieving positive Adjusted

Montreal , Quebec , Canada , Tennessee , United-states , San-antonio , Texas , France , America , Daniel-petrylak , Julie-schneiderman , Christian-marsolais

Open Letter to Shareholders from CEO Paul Levesque

FY2022 top line revenue expected to end the year at ~$80 million, in line with previously announced revenue guidanceFY2023 revenue guidance range set between $90 million and $95 million, ending

Montreal , Quebec , Canada , United-states , Elif-mcdonald , Julie-schneiderman , Taimed-biologics , International-financial-reporting-standards , Scientific-advisory-committee , Drug-administration , Theratechnologies-inc , Communications-corporate-affairs

DelveInsight Business Research, LLP: Genital Herpes Market to Exhibit Growth at a CAGR of 3.2% by 2032

The genital herpes market is expected to grow significantly owing to the increase in diagnosed genital herpes cases per year, awareness, and anticipated launch of emerging therapies by key players

China , Shruti-thakur , Kostenloser-wertpapierhandel , Heidelberg-immunotherapeutics , Taimed-biologics , Genocea-biosciences , Evofem-biosciences , Abera-bioscience , Glaxosmithkline , Market-research , Healthcare-due-diligence-services , Key-genital-herpes-companies

Genital Herpes Market to Exhibit Growth at a CAGR of 3.2% by 2032

/PRNewswire/ -- DelveInsight's Genital Herpes Market Insights report includes a comprehensive understanding of current treatment practices, genital herpes...

China , Shruti-thakur , Heidelberg-immunotherapeutics , Taimed-biologics , Genocea-biosciences , Evofem-biosciences , Abera-bioscience , Glaxosmithkline , Healthcare-due-diligence-services , Key-genital-herpes-companies , Rational-vaccines-inc , Market-research

InsightAce Analytic Pvt. Ltd: Investigational New Drug CDMO Market worth $7.47 billion by 2030 - Exclusive Report by InsightAce Analytic

JERSEY CITY, N.J., Sept. 27, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the 'Global Investigational New Drug CDMO Market By Product

Jersey , Germany , Mexico , United-states , New-zealand , India , Brazil , China , South-africa , South-korea , Canada , Russia